Black women have a higher rate of developing more aggressive tumors at earlier stages that often go mischaracterized. Despite ...

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines help ...

Researchers compared clinicopathologic features, MammaPrint and BluePrint molecular subtype, and outcomes by race among patients with HR+, HER2− early-stage breast cancer.

Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and ...

A single injection of a redesigned immune-stimulating antibody directly into a tumor was linked to shrinkage not only at the ...

About The Study: Among childhood cancer survivors in this cohort study, obesity was associated with an increased risk for multiple subsequent neoplasm types, while higher physical activity was ...

Princeton researchers have revealed new links between high-fat diets and aggressive breast cancer, demonstrating the ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

Researchers have found that a group of immune cells can suppress the body’s cancer-fighting response after radiation therapy.

A therapy that targets a mutation in a critical tumor suppressor gene exhibited “impressive” activity in a cohort of heavily ...